Fox Run Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,112
Closed -$582K 979
2025
Q4
$582K Buy
+9,112
New +$562K 0.09% 430
2023
Q1
Sell
-15,233
Closed -$1.24M 729
2022
Q4
$1.24M Buy
+15,233
New +$1.23M 0.5% 6
2021
Q4
Sell
-6,027
Closed -$607K 533
2021
Q3
$607K Buy
+6,027
New +$665K 0.38% 45
2021
Q2
Sell
-2,210
Closed -$243K 374
2021
Q1
$243K Buy
+2,210
New +$240K 0.44% 122
2019
Q2
Sell
-3,995
Closed -$303K 478
2019
Q1
$303K Buy
+3,995
New +$318K 0.17% 265
2018
Q3
Sell
-2,527
Closed -$253K 635
2018
Q2
$253K Buy
+2,527
New +$267K 0.08% 497
2016
Q4
Sell
-12,300
Closed -$832K 542
2016
Q3
$832K Buy
+12,300
New +$825K 0.49% 11

Other funds holding EMN

Fox Run Management's EMN Position: Q1 2026 in Review

Fox Run Management sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 9,112 shares — an estimated $582K sold.

Fox Run Management first reported a position in EMN in Q3 2016 and held it in 7 quarters. The position peaked at $1.24M in Q4 2022. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Fox Run Management reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
  • Fox Run Management sold 9,112 Eastman Chemical shares in Q1 2026, an estimated $582K.
  • Fox Run Management first reported a position in Eastman Chemical in Q3 2016 and held it in 7 quarters.
  • Fox Run Management's Eastman Chemical position peaked at $1.24M in Q4 2022.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.